Airway pressure release ventilation (APRV) is a comparatively new mode of ventilation which was first described in 1987 1 . This method has been shown to be an effective therapeutic strategy for lung-injured patients with acute respiratory distress syndrome and acute lung injury. APRV has also been demonstrated to preserve spontaneous breathing. This leads to decreased peak airway pressure and improved oxygenation as compared to other methods of ventilation.
It has been shown that static haemodynamic parameters (including central venous pressure [CVP] , pulmonary capillary wedge pressure and left ventricular end diastolic area) cannot predict fluid responsiveness accurately [2] [3] [4] [5] [6] [7] . The Vigileo-FloTrac™ system (Edwards Lifesciences, Irvine, CA) is a new device that enables automatic measurement of continuous cardiac output (CO) by pulse contour analysis. The ability of this device to measure CO has been investigated in numerous settings with various results [8] [9] [10] [11] [12] , while measuring stroke volume variation (SVV) via this system has been reported to predict fluid responsiveness in mechanically ventilated patients with high levels of sensitivity and specificity 13 . The reliability of SVV to predict fluid responsiveness in patients ventilated with APRV has not been fully evaluated. Inappropriate fluid loading in mechanically ventilated, critically ill patients may lead to pulmonary oedema; thus, a method to predict fluid responsiveness is especially important for lung-injured patients to limit unnecessary fluid administration. To predict whether a haemodynamically unstable patient SUMMARy we investigated the effectiveness of stroke volume variation (SVV) shown by the Vigileo-FloTrac™ system (Edwards Lifesciences, Irvine, CA) to predict fluid responsiveness in patients undergoing airway pressure release ventilation (APRV).
All 80 patients mechanically ventilated in the intensive care unit of our hospital from April to november 2010 were included in this study. After starting APRV, Ringer's lactate solution was administered for 30 minutes. haemodynamic variables including heart rate, mean arterial pressure, cardiac index (CI), stroke volume index (SVI) and SVV were measured before and after volume loading.
SVV before volume loading was significantly correlated with absolute change in SVV (ΔSVV) and percentage change in stroke volume index (ΔSVI) after volume loading (ΔSVV: P <0.05, r 2 =0.534; ΔSVI: P <0.05, r 2 =0.217). Of the 80 patients, 38 (47.5%) were responders to intravascular volume expansion (increase in CI ≥15%) and 42 (52.5%) were non-responders (increase in CI <15%). Receiver operating characteristic (ROC) curves were generated for SVV and central venous pressure by varying the discriminating threshold of the variable and areas under the ROC curves were calculated. The areas under the ROC curves were 0.793 for SVV (95% confidence interval: 0.709-0.877) and 0.442 for central venous pressure (95% confidence interval: 0.336-0.549), which were significantly different (P <0.05). The optimal threshold value of SVV to discriminate between responders and nonresponders was 14% (sensitivity: 78.9%; specificity: 64.3%). we found that SVV was able to predict fluid responsiveness in patients undergoing APRV with acceptable levels of sensitivity and specificity.
will respond to volume loading with an increase in CO determines the initial therapeutic strategy of whether to administer fluid or use catecholamines. The aim of this study was to investigate whether the SVV shown by the Vigileo-FloTrac system can predict fluid responsiveness in patients ventilated with APRV.
SUBJECTS AnD METhODS
This study was approved by the Clinical Research Ethics Committee of our institution and informed written consent for the clinical procedure was obtained from next of kin. Patients who were mechanically ventilated in the intensive care unit of our hospital from April to november 2010 were included in this study. Exclusion criteria were cardiac arrhythmias (atrial fibrillation or frequent premature beats) and severe obesity (body mass index ≥35). All patients were monitored with electrocardiogram, percutaneous oxygen saturation, invasive arterial pressure, non-invasive arterial pressure and endtidal carbon dioxide. A 20-gauge elastic catheter was inserted into the radial artery and connected to V3.02 of the Vigileo-FloTrac system. CO and SVV were measured using the Vigileo-FloTrac system.
we used a standard ventilator (Evita ® , Dräger Medical AG & Co., Lubeck, Germany) to perform APRV, which made it possible to preserve spontaneous breathing throughout the ventilatory cycle at two airway pressure levels. Besides slope of the pressure curve and fraction of inspired oxygen, we controlled the four variables (P high , P low , T high , and T low ) which were set at 20 cmh 2 O, 0 cmh 2 O, 4 seconds and 0.8 seconds respectively.
Automated calculation of SVV
The Vigileo-FloTrac system does not require prior calibration and measures stroke volume (SV) with arterial pressure waveform analysis. The VigileoFloTrac system calculates CO using the haemodynamic data in 20 seconds. To calculate CO, the software uses an algorithm according to the relationship between arterial pressure and SV, and sets the K value every 60 seconds. The K value is a constant quantifying peripheral vascular resistance and vessel compliance. Vessel compliance is estimated with nomograms according to gender, age, weight and height, while the arterial resistance is decided from arterial waveform characteristics 13 . SVV is calculated as the difference between the maximum and minimum values of SV during one mechanical breath divided by the mean of the two values.
Experimental protocol
we investigated the reliability of SVV to predict fluid responsiveness in patients ventilated with APRV. All patients were administered 2 ml/kg/hour of Ringer's lactate solution during the study. we began our experimental protocol 30 minutes after starting APRV. After obtaining stable haemodynamic parameters in five minutes, intravascular volume expansion was performed with 500 ml of Ringer's lactate solution administered for 30 minutes. we recorded haemodynamic parameters (including mean arterial pressure, heart rate, SVV, stroke volume index [SVI] and cardiac index [CI]) before (five minutes, T1) and after (five minutes, T2) volume administration ( Figure 1 ).
we did not perform volume loading steps when stable baseline haemodynamic parameters were not Figure  Figure 1 .
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Figure 1: Time course of sample points T1 and T2. All patients were studied 30 minutes after starting airway pressure release ventilation. After a period of five minutes of stable heart rate, blood pressure, cardiac output, stroke volume and stroke volume variation measurements, 500 ml of lactate Ringer's solution was administered for 30 minutes. haemodynamic parameters (including heart rate, mean arterial pressure, cardiac index, stroke volume index and stroke volume variation) were measured before (five minutes, T1) and after (five minutes, T2) volume administration.
obtained for five minutes. Also, additional vasoactive drugs were not administered during the experimental protocol.
Statistical analysis
we performed statistical analysis using a statistical software package (ystat2004.xls, Igakutosho Shuppan, Tokyo, Japan). haemodynamic parameters (mean arterial pressure, heart rate, SVV, SVI, CI) measured at T1 and T2 were compared using Student's t-test. we defined percentage changes in SVI and absolute changes in SVV after volume loading as ΔSVI and ΔSVV respectively. The correlations among the SVV value at T1, ΔSVI and ΔSVV were assessed by Pearson's correlation coefficient. A P <0.05 was considered statistically significant. we divided the patients into two groups according to the percentage increases in CI after volume loading with responders defined as those who showed an increase in CI ≥15% after volume loading and nonresponders as those with a CI change <15%. we made receiver operating characteristic (ROC) curves for SVV and CVP by varying the discriminating threshold of these parameters and calculated areas under the ROC curves. 
RESULTS
A total of 80 patients were enrolled in this study. Table 1 shows the patient characteristics. Massive blood loss (>50 ml) was not seen in any case. no patient was administered additional vasoactive agents during the experimental protocol. The haemodynamic parameters at T1 and T2 are shown in Table 2 . CI, SVI and SVV were significantly changed (P <0.05) after intravascular volume expansion (between T1 and T2). Figure 2 shows the results of correlation analysis among SVV values at T1, ΔSVI and ΔSVV after volume loading. The SVV value at baseline (T1) was significantly correlated with ΔSVI and ΔSVV (ΔSVI: P <0.05, r 2 =0.217; ΔSVV: P <0.05, r 2 =0.534). Of the 80 patients, 38 (47.5%) were responders to volume loading and 42 (52.5%) were nonresponders. Table 3 shows the haemodynamic variables before volume administration (T1). There were significant differences between responders and nonresponders for heart rate, SVI and SVV; tidal volume was not significantly different between the groups. ROC curves were generated to evaluate the ability of SVV to predict the responsiveness of CI to volume loading (Figure 3 ). The areas under the ROC curve were 0.793 for SVV (95% confidence interval: 0.709-0.877) and 0.442 for CVP (95% confidence interval: 0.336-0.549), a significant difference (P <0.05). The optimal threshold value for SVV to discriminate between responders and nonresponders was 14% (sensitivity: 78.9%; specificity: 64.3%).
DISCUSSIOn
In this study we found the reliability of SVV to predict fluid responsiveness in patients ventilated with APRV to be clinically acceptable. As shown by ROC analysis, the optimal threshold value to predict the responders was 14% for SVV. Thus patients undergoing APRV with an SVV value greater than 14% will respond to fluid administration by an increase in CI >15% with sensitivity and specificity found to be 78.9 and 64.3% respectively. The area under the ROC curve for SVV was higher compared to that for CVP (P <0.05). This finding indicated that the reliability of SVV to predict fluid responsiveness was significantly better than that of CVP in patients receiving APRV.
Predicting fluid responsiveness is an issue of great importance for critically ill patients. As shown in several studies, functional haemodynamic indicators, such as pulse pressure variation, systolic pressure variation and SVV, were highly useful for predicting fluid responsiveness in patients undergoing mechanical ventilation [2] [3] [4] [5] [6] [7] 14 , while CVP and pulmonary Receiver operating characteristic curves comparing the ability of central venous pressure and stroke volume variation at baseline to discriminate responders and non-responders to volume loading. The areas under the receiver operating characteristic curve were 0.793 for stroke volume variation (95% confidence interval: 0.709-0.877) and 0.442 for central venous pressure (95% confidence interval: 0.336-0.549). The areas for stroke volume variation were significantly higher than the area for central venous pressure (P <0.05). The optimal threshold value of stroke volume variation to discriminate between responders and non-responders was 14% (sensitivity: 78.9%, specificity: 64.3%). SVV=stroke volume variation, CVP=central venous pressure. [15] [16] [17] [18] [19] . however, the inability of most current haemodynamic indicators to be continuously and automatically monitored is a major limitation when caring for critically ill patients 20 . The Vigileo-FloTrac system provides continuous and automatic monitoring of SVV that is simple to estimate and shows fluid responsiveness in mechanically ventilated patients. During mechanical ventilation, the right ventricular SV decrease in inspiratory cycle is proportional to the degree of hypovolaemia and transmitted to the left ventricle after two or three beats. The results of our study indicate that SVV measured by the Vigileo-FloTrac system can serve as a predictor of fluid responsiveness in patients ventilated with APRV, as shown by the correlations between SVV at T1, ΔSVI and ΔSVV. These high correlations showed a relationship between ventilation-associated SVV value at baseline and the amounts of SVV decrease, and the CI increase following volume administration.
A recent study presented by huang et al 21 showed the ability of pulse pressure variation to predict fluid responsiveness in acute respiratory distress syndrome patients ventilated with protective strategy (low tidal volume [6.4 ml/kg], high positive end-expiratory pressure [PEEP] [14 cmh 2 O]). They reported that a threshold pulse pressure variation value of 11.8% allowed discrimination of responders to volume loading with a sensitivity of 68% and specificity of 100%. Those results were supported by the results of the present study. however, the threshold SVV value in the present study was higher than that in another study by Cannesson et al 13 . They reported that a threshold SVV value of 10% allowed discrimination of responders to volume loading with a sensitivity of 82% and specificity of 88% in mechanically ventilated patients. we speculated that the high PEEP of the APRV ventilatory cycle causes an increase in the SVV threshold. There are complex interactions between left ventricular function and mechanical ventilation. SVV may also be affected by cardiovascular and ventilator issues [22] [23] [24] [25] [26] [27] [28] . PEEP increases the mechanical compressive force that lung expansion exerts on the heart during mechanical ventilation. Additionally, PEEP decreases venous return by direct compression of the vena cava inferior. Consequently, in patients ventilated with high PEEP, cardiac preload and right ventricular end-diastolic volume decrease 28 . As shown in the study by Kubitz et al 28 , application of PEEP led to a reduction in stroke volume and an increase in SVV.
The reliability of SVV to predict fluid responsiveness to intravascular volume expansion and utility of continuous SVV measurements are of utmost clinical importance. Since the relationship between preload and CO in defined contractility is not linear, the reliability to predict whether the cardiac function will increase after volume loading or whether inotropes are needed is very important. This ability may decrease unnecessary fluid administration which is highly significant in critically ill patients.
Since the Vigileo-FloTrac system is still under investigation for use in APRV patients, this could be seen as a limitation of our study. SVV values shown by the Vigileo-FloTrac system must be obtained after periods of haemodynamic stability to avoid misleading values induced by acute haemodynamic changes. Thus before measuring SVV it is important to obtain a stable haemodynamic state 13 . In this study we excluded the patients with arrhythmias and haemodynamic instability before the intervention. Another limitation is that APRV allows for spontaneous breathing which leads to variable tidal volume and may cause changes in SVV. however, as shown in Table 3 , tidal volume was not significantly different between responders and nonresponders and therefore it might not affect changes in SVV. nevertheless, even with these limitations, our findings indicated that SVV values shown by the Vigileo-FloTrac system were a reliable predictor of fluid responsiveness in patients ventilated with APRV.
COnCLUSIOnS
In the present study we investigated the reliability of SVV to predict fluid responsiveness in patients ventilated with APRV. we found that SVV values measured by the Vigileo-FloTrac system were clinically reliable to predict fluid responsiveness in patients receiving APRV with acceptable levels of sensitivity and specificity.
